Imprivata (IMPR) : The highest level Imprivata (IMPR) is projected to reach is $20 for the short term and the lowest estimate is at $14. The consolidated price target from 5 rating analysts who initiate coverage on the stock is $17 and the possibility the share price can swing is $2.24.
Imprivata (IMPR) has witnessed a rise of 20.8% or 191,600 shares in its short figure. The short interest augmentation took it from 919,769 on June 15,2016 to 1,111,369 on June 30,2016. In terms of floated shares, the short interest was calculated to be 7%. The days to cover are 5 given that the daily volume averaged 211,354 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.
Also, Equity Analysts at the Brokerage Firm, Leerink Swann, maintains their rating on the shares of Imprivata (NYSE:IMPR). Leerink Swann has a Outperform rating on the shares. As per the latest research report, the brokerage house raises the price target to $16 per share from a prior target of $13. The rating by the firm was issued on May 4, 2016.
Imprivata (NYSE:IMPR): On Thursdays trading session , Opening price of the stock was $19.01 with an intraday high of $19.06. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $19. However, the stock managed to close at $19, a loss of 0.05% for the day. On the previous day, the stock had closed at $19.01. The total traded volume of the day was 3,382,029 shares.
Imprivata, Inc. is a provider of healthcare information technology) IT security solutions. The Companys solutions provide authentication management, access to patient information and communications technologies to the healthcare industry. Its solutions include Imprivata OneSign, Imprivata Cortext and Imprivata Confirm ID. Imprivata OneSign is a suite of authentication and access management products, which consists of three offerings: authentication management, enterprise single sign-on and workflow automation. Imprivata Cortext is a cloud-supported communications platform that provides healthcare organizations with texting and messaging services. Imprivata Confirm ID is a software product for electronic prescribing of controlled substances (EPCS).